• CRO M&A Market in 2020 (So Far)

    There haven’t been many deals targeting contract research organizations (CRO) in 2020, especially compared to previous years, which makes sense. Life science companies are all slowing down clinical trials (COVID-19 vaccine research excluded) to adhere to social distancing guidelines, meaning CRO services are just not in as high demand. For... Read More »
  • Ophthalmology Groups Are Still Selling

    Despite the effects of COVID-19 on physician groups, investors are still acquiring ophthalmology groups, especially in the third quarter, according to DSO. Just last week, EyeSouth Partners acquired Retina Associates of Middle Georgia (RAMG) for an undisclosed sum. Based in Macon, Georgia, RAMG provides treatment for the retina, macula, and... Read More »
  • Hospice M&A Activity Surges in 2020

    Despite the volatile market conditions for healthcare M&A, hospice targets have remained a remarkably consistent draw for investors, according to data captured in DSO. In the second quarter of 2020, 70% of HH&H transactions were for hospice specific targets, or targets that provided only hospice services, instead of a mix of hospice and... Read More »
  • Teladoc Health and Livongo Health Merge

    The virtual care giant Teladoc Health, Inc. (NYSE: TDOC) is having a wild year. The company’s second-quarter earnings reports showed Teladoc’s year-over-year revenues surged by 85% to $241 million, and its total telehealth visits rose to 2.8 million, a year-over-year increase of 203%, all thanks to the effects of COVD-19. And now,... Read More »
  • Health Care M&A Deals, August 7, 2020

    The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week was... Read More »
athenahealth Finds a Buyer and a Merger Partner

athenahealth Finds a Buyer and a Merger Partner

Only two weeks into the month of November 2018, and already the deal value is higher than all of October. Through November 14, nearly $9.8 billion has been spent, but that’s largely because of a single deal, and one that’s been long in the works. After a lengthy bidding process, athenahealth (NASDAQ: ATHN) was acquired by Veritas Capital and Evergreen Coast Capital, the private equity subsidiary of activist investor group Elliott Management Corporation. athenahealth’s focus is on hospital and ambulatory customers and its products range from medical records, revenue cycle, patient engagement, care coordination and population health services. The final price of... Read More »
Veritas Capital Doubles Down on Digital Health

Veritas Capital Doubles Down on Digital Health

Veritas Capital Management has made some aggressive moves into the digital health space in recent years. Its investment focus is on companies that provide critical products and services, not just in healthcare, but also in aerospace and defense, communications, energy and education. So its recent activity is interesting, and expensive. In April 2016, Veritas paid $820 million to acquire Verisk Health from its parent, Verisk Analytics, Inc. (NASDAQ: VRSK). Verisk Health provides data services, analytics and advanced technology to support value-based healthcare delivery and payment systems. At the time of the sale, it had 350 clients in the United States. The price consisted of $720 million... Read More »

Veritas Capital Buys Back into Big Data

Big data firms are sweet targets for healthcare investors. Just last February, Veritas Capital sold Truven Health Analytics to IBM Watson Health (NYSE: IBM) for $2.6 billion. Now it’s putting some of that ROI into another big data firm, Verisk Health, the healthcare service business Verisk Analytics Inc. Verisk Health provides data services, analytics and advanced technologies to help users make smarter business decisions and reduce risk. The $820 million purchase price consists of $720 million in cash and a $100 million long-term subordinated promissory note. With Truven Health Analytics, Veritas Capital repositioned the company from a data provider with limited analytics offerings... Read More »